See the Whole Landscape Shape What's Next in Pharma
GBI Health unites global pharmaceutical data, AI capabilities and industry expertise to deliver future-ready solutions across the entire product lifecycle.
Products
GBI Health Data Intelligence Suite
Solutions
Full Life-Cycle Solutions for Pharmaceuticals
Powered by global drug pipeline data, the Competitive Landscape Analysis solution enables multidimensional analysis across drugs, targets, indications, and technologies. It helps R&D teams identify strategic opportunities, prioritize investments, and make more informed development decisions.
Drawing on data from six major global clinical trial registries, the Clinical R&D Insights solution provides deep visibility into global trial activity and protocol designs, helping teams optimize clinical development strategies and trial execution.
Drawing on data covering the National Reimbursement Drug List (NRDL), public procurement and tendering, Huiminbao (commercial health insurance), Patient Assistance Programs (PAPs), and healthcare policies and regulations, the Market Access Strategy solution supports market access planning, pricing analysis, and regional opportunity assessment to accelerate commercialization and market access.
Built on comprehensive researcher profiles, the GBI KOL/HCP Management solution enables researcher identification, segmentation, academic influence analysis, and collaboration network mapping, helping Medical Affairs, Marketing, and Sales teams improve researcher engagement and operational efficiency.
Industry News and Reports
Aggregating industry news and in-depth reports to help pharma companies stay ahead.
- Novo Nordisk's insulin icodec/semaglutide approved for new indication in China
On October 15, 2026, Novo Nordisk (NYSE: NVO) announced that the National Medical Products Administration (NMPA) of China has approved a new indication for NovoGlic (insulin icodec/semaglutide injection).
- ChemPartner Pharmatech Joins Hands with BioBAY to Establish Arsenal Innovation Center in the U.S.
On September 25, 2026, the Arsenal Innovation Center (hereinafter referred to as the "Arsenal Innovation Center"), established by ChemPartner Pharmatech in collaboration with BioBAY, held its opening ceremony in Watertown, Massachusetts.
- Keymed's Stapokibart Adds New Adolescent AD Indication, Records RMB 660m in First Three Quarters
On October 16, 2026, Keymed Biosciences (2162.HK) announced that a new indication for Kangyueda (stapokibart) has been approved for marketing by the National Medical Products Administration for the treatment of moderate-to-severe atopic dermatitis (AD) in adolescents aged 12 years and older.
- Walvax Biotechnology initiates clinical trial for lyophilized herpes zoster mRNA vaccine in China
On October 14, 2026, Walvax Biotechnology Co., Ltd. (300142.SZ) announced that the Phase I clinical trial for its lyophilized herpes zoster (shingles) mRNA vaccine, co-developed with Fudan University and RQ Biotech, has officially been initiated.
- insitro collaborates with AstraZeneca for AI-enabled drug development
On October 15, 2026, insitro announced a worldwide exclusive research collaboration agreement with AstraZeneca to discover novel targets and therapeutics in metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies.
- Legend Biotech's CD19/CD20 Dual-Target Off-the-Shelf CAR-T Therapy LB2501 Nails FDA Clinical Approval
On October 15, 2026, Legend Biotech (NASDAQ: LEGN) announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for LB2501.
In-Depth, Exclusive Industry Reports
Curated by expert analysts, offering in-depth analysis of emerging industry trends and the competitive landscape.
Scan the QR code to follow the GBIHealth WeChat Official Account for industry news, live webinars, thematic reports, and more.
Reliable partner for 95%+ key global medical industry players
Our clients are drawn from across pharma, medical device firms, CROs/CDMOs, investors, consulting firms, and others
See the Whole Landscape Shape What's Next in Pharma
GBI Health unites global pharmaceutical data, AI capabilities and industry expertise to deliver future-ready solutions across the entire product lifecycle.
Contact Us